Heartcore Enterprises, Inc. · NASDAQ:HTCR

Heartcore Enterprises — Investor Presentation (February 2026)

14 slides from Heartcore Enterprises's investor presentation, February 2026

  1. Slide 1: Investor Presentation

    Investor Presentation Nasdaq: HTCR February 2026 1

  2. Slide 2: Forward-Looking Statements

    Forward-Looking Statements Certain information set forth in this presentation contains forward-looking statements within the meaning of Section 27 A of the Securities Act of 1933, as amended, Section 21 E of the Securities Exchange Act of 1934, as amended, or the Private Securities Litigation Reform

  3. Slide 3: HeartCore Software Business Divestiture

    HeartCore Software Business Divestiture Divestiture Details Divestiture Rationale • On October 31, 2025, HeartCore completed the “The rapid evolution of generative AI has fundamentally sale of its subsidiary, HeartCore Co. Ltd. reshaped the competitive landscape for traditional software (“HeartCore

  4. Slide 4: Go IPO Business

    Go IPO Business HeartCore’s Go IPO consulting business provides Japanese companies with comprehensive consultation support, including pre-IPO consulting, regulatory guidance, financial preparation, and operational readiness to help businesses navigate the complexities of a successful U.S. listing. H

  5. Slide 5: Go IPO Results & Tailwinds

    Go IPO Business Go IPO Results & Tailwinds Tokyo Stock Exchange (TSE) Growth Market Listing Rules $14.7M • The TSE raised the minimum market capitalization required for continued FY2024 Revenue listing for Growth Market-listed companies • Effective March 1, 2030, listed companies that have been publ

  6. Slide 6: Revenue Recognition Model

    Go IPO Business Revenue Recognition Model Go IPO Fee Structure Consulting Fee HeartCore’s Go IPO business engages The cash consideration is paid in installment payments and is recognized as revenues over the period of the contract, based on Japanese growth companies who view U.S. progress toward the

  7. Slide 7: SBC Medical Group Holdings Inc.

    Go IPO Business SBC Medical Group Holdings Inc. Client Target Go IPO Services SBC Medical Group Holdings Inc., through its HeartCore spearheaded the entire listing process and supported the subsidiaries, provides operational management successful listing of SBC Medical Group Holdings, Inc. (NASDAQ:

  8. Slide 8: South Korea Expansion

    Go IPO Business South Korea Expansion CBA Partnership Launched sales and marketing initiative across the broader Asia Pacific region Established a referral program with Cross Border Association (CBA) Engaged in active discussion with other firms across South Korea and the Asia Pacific region who vie

  9. Slide 9: Financial Highlights

    Financial Highlights Preliminary Full Year 2025 Highlights Q3 2025 9 mo. 2025 • Revenue to be in the range of $8.5 million to $9.5 Revenue $3.0 Million $7.1 Million million • Net income to be in the range of $3.0 million to Gross Profit $1.5 Million $2.6 Million $4.0 million Net Income (Loss) $0.4 M

  10. Slide 10: About Management Team

    About Management Team Sumitaka Kanno Yamamoto Chairman of Board, Chief Executive Officer, President and Director After graduating from the Kansai Gaidai University in Japan, Kanno joined the Japan Air Force and became a pilot. He then founded his own company, popularized snowboarding in Japan, and c

  11. Slide 11: Investor Relations

    INVESTOR RELATIONS Gateway Group, Inc. John Yi and Steven Shinmachi HTCR@gateway-grp.com (949) 574-3860 WEBSITE https://heartcore-enterprises.com/

  12. Slide 12: Appendix

    APPENDIX

  13. Slide 13: Revenue Breakdown

    Revenue Breakdown For the Three Months Ended For the Nine Months Ended September 30, September 30, 2025 2024 2025 2024 Revenues from software development services $ 9,008 $ 113,011 $ 25,383 $ 117,092 Revenues from customized software development and services 1,738,336 2,243,504 5,360,897 6,543,156 R

  14. Slide 14: Non-GAAP Financial Measure

    Non-GAAP Financial Measure For the Three Months Ended For the Nine Months Ended September 30, September 30, 2025 2024 2025 2024 Net Income (Loss) $ 351,175 $ 10,816,930 $ (1,724,700) $ 7,127,810 (+) Depreciation and amortization expense 8,265 17,147 36,994 532,958 (+) Changes in fair value of invest

HeartCore Enterprises — Investor Presentation (February 2026) on 6ix